Research Study to Compare the Addition of Topaz Micro Debridement to the Standard of Care Surgery
A Randomised, Controlled, Double-blind Clinical Investigation on the Efficacy and Safety of Radiofrequency Micro Debridement, Topaz, in Recalcitrant Greater Trochanteric Pain Syndrome (GTPS) vs. Standard of Care
Sponsor: Smith & Nephew, Inc.
Listed as NCT01562366, this NA trial focuses on Greater Trochanteric Pain Syndrome and Hip Pain Chronic and remains completed. Sponsored by Smith & Nephew, Inc., it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2017 — Jun 2018 [monthly]
Completed NA
Phase: PHASE4 → NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2017 [monthly]
Completed PHASE4
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Smith & Nephew, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .